benevolent.ai Logo

benevolent.ai

AI-powered drug discovery for biopharma

10k 热度 AI医疗 AI drug discovery Biopharma research Data-driven drug innovation AI-powered drug development
访问官网
benevolent.ai 截图

软件新闻

Martin Frederik, Snowflake: Data quality is key to AI-driven growth

发布日期:2025-09-23

As companies race to implement AI, many are finding that project success hinges directly on the quality of their data. This dependency is causing many ambitious initiatives to stall, never making it beyond the experimental proof-of-concept stage. So, what’s the secret to turning these experiments into real revenue generators? AI News caught up with Martin […] The post Martin Frederik, Snowflake: Data quality is key to AI-driven growth appeared first on AI News.

Christian Spindeldreher, Dell Technologies: Powering AI at scale

发布日期:2025-09-19

Dell Technologies is betting on AI as companies move from small pilots to full-scale deployments, with the focus now on how organisations can turn AI into measurable results. But scaling AI is not easy. It demands strong infrastructure, reliable data management, and the ability to deploy models quickly in different workflows. Dell has positioned itself […] The post Christian Spindeldreher, Dell Technologies: Powering AI at scale appeared first on AI News.

Trump jokes about AI while US and UK sign new tech deal

发布日期:2025-09-19

US President Donald Trump said on Thursday that AI was “taking over the world,” and joked that he hoped tech executives understood it better than he did. The comment came as Trump and UK Prime Minister Keir Starmer hosted a gathering of business and technology leaders in London during the president’s second state visit to […] The post Trump jokes about AI while US and UK sign new tech deal appeared first on AI News.

AI-enabled threats and stricter regulation in France

发布日期:2025-09-17

A new research report from technology advisory firm Information Services Group (ISG) has revealed AI threats and more stringent regulations are shifting the French cybersecurity landscape, resulting in businesses reassessing their security strategies. Increasing security budgets mean many French enterprises require fresh guidance and expertise to establish effective priorities and combat their security challenges. According […] The post AI-enabled threats and stricter regulation in France appeared first on AI News.

CSI and HuLoop deliver AI-driven efficiency to banks

发布日期:2025-09-17

Fintech, regtech, and cybersecurity vendor, CSI has teamed with HuLoop, a provider of an AI-powered, no-code automation platform, to help banks improve efficiency. The partnership will present CSI’s NuPoint Core Banking System to financial institutions, and is designed to help companies manage accounts, transactions, and other banking operations. NuPoint customers will have access to HuLoop’s […] The post CSI and HuLoop deliver AI-driven efficiency to banks appeared first on AI News.

Mythos AI and lomarlabs deploy sea-pilot AI assistance

发布日期:2025-09-15

American maritime technology company Mythos AI has completed the installation of its Advanced Pilot Assistance System (APAS) aboard the vessel CB Pacific, a chemical cargo ship owned by CB Tankers. The APAS project is designed to manage navigation at sea. Unlike most traditional systems in this space that depend largely on machine vision, APAS uses […] The post Mythos AI and lomarlabs deploy sea-pilot AI assistance appeared first on AI News.

使用指南

What is BenevolentAI?

BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery. They use AI to empower scientists to uncover new insights from data, helping to accelerate innovation and increase the probability of discovering a successful drug.

How to use BenevolentAI?

Users can access the AI-powered drug discovery platform and tools on the BenevolentAI website by signing up and gaining access to the versatile, scalable, and robust AI-enabled drug discovery platform.

BenevolentAI's Core Features

AI-enabled drug discovery platform

BenevolentAI's Use Cases

#1

Empowering scientists to accelerate drug discovery

#2

Uncovering new insights from data

FAQ from BenevolentAI

What is the primary focus of BenevolentAI's AI application?

How can I access the AI-powered drug discovery platform?

BenevolentAI Support Email & Customer service contact & Refund contact etc.

More Contact, visit

the contact us page(https://www.benevolent.com/contact-us/)

BenevolentAI Company

BenevolentAI Company name:

BenevolentAI

.

BenevolentAI Company address:

4-8 Maple Street London W1T 5HD

.

More about BenevolentAI, Please visit

the about us page(https://www.benevolent.com/about-us/)

.

BenevolentAI Facebook

BenevolentAI Facebook Link:

https://www.facebook.com/BenevolentAI/

BenevolentAI Youtube

BenevolentAI Youtube Link:

https://www.youtube.com/benevolentai

BenevolentAI Linkedin

BenevolentAI Linkedin Link:

http://linkedin.com/company/benevolentai/

BenevolentAI Twitter

BenevolentAI Twitter Link:

https://twitter.com/benevolent_ai

你可能还感兴趣